Aug 2026· Indian Journal of Radiology and Imaging· 0 citations· 7 references
TL;DR
The authors are commend the authors for addressing the clinically important question of preoperative imaging biomarkers for survival prediction in glioblastoma (GBM), however, several methodological, data integrity concerns are raised.
Abstract
We read with great interest the article by Thomas et al. 1 We commend the authors for addressing the clinically important question of preoperative imaging biomarkers for survival prediction in glioblastoma (GBM). However, several methodological, data integrity
Currently, there is no clear guidance on the appropriate population or timing for adaptive radiotherapy (ART) in high‐grade glioma (HGG) patients. This study aims to provide individualized ART for HGG patients.
Shuangshuang He, Hang Yu, Yuan Yang et al.· Cancer Medicine· 0 citations
Aim To evaluate whether longitudinal multiparametric MRI biomarkers can classify clinically meaningful treatment-response states and identify progression in treated gliomas.
Akshat Shah, S. Sen, Aditi Chandra et al.· Cancer Imaging· 0 citations
A multimodal signature integrated CT radiomics, deep learning, and pathomics combined to predict progression-free survival in independent cohorts and may support postoperative risk stratification.
Qiushi Su, Jie Wu, Ben Li et al.· Translational Oncology· 0 citations
This cohort study evaluates rates of magnetic resonance imaging (MRI) use prior to prostate biopsy in the US from January 2017 to June 2026, as support for this practice continues to increase.
Stephen Rhodes, S. Basourakos, Jim C. Hu et al.· JAMA Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
